Blindspot Capital

Some markets follow a familiar script: a need emerges, founders respond, capital flows, and eventually, the sector matures. But women’s health doesn’t work like that. In a recent episode of Blindspot Capital, I sat down with Hotflash inc menopause + midlife by Ann Marie McQueen to explore what happens when a market begins not with products or funding but with missing information. When Ann-Marie la...

Some markets follow this script: A need appears. Entrepreneurs respond. Capital flows in. Eventually, the sector matures and innovation accelerates. But some markets don’t follow that script. In a recent episode of Blindspot Capital, I sat down with Lindsay Davis , founder of FemTech Association Asia , to talk about what it actually takes to build women’s health markets in Southeast Asia. When Lin...

In this episode of Blindspot Capital, Maryann sits down with Cristina Ljungberg and Wendy Anderson , co-founders of The Case for Her , to unpack what happens before venture capital shows up. For 15 years, The Case for Her has deployed catalytic capital across menstruation, sexual wellness, and reproductive health to make markets legible enough for venture to follow. What started with two women put...

Most innovation stories are told as clean upward lines. A founder has an idea. Investors come in. The product launches. Growth follows. Eventually there is an acquisition or an IPO, and the story looks inevitable in hindsight. But in women’s health, progress rarely looks like that. More often, there is a long stretch where the science works and yet nothing seems to move. Inside that stretch, entre...

In this episode of Blindspot Capital, Maryann sits down with Professor Angela Maas (cardiologist and pioneer of sex- and gender-specific cardiology) to unpack why women’s heart disease is still misunderstood and what medicine, policy, and innovation must change to close the gap. Angela has built her career at the frontier of women’s cardiovascular science and clinical practice. Her work helped shi...

In this episode of Blindspot Capital, Maryann Selfe speaks with Professor Carolin Lerchenmüller, cardiologist, clinician-scientist, and Switzerland’s first Chair of Gender Medicine , about why heart disease presents differently in women and how hormones across pregnancy, perimenopause, and menopause fundamentally reshape cardiovascular risk. Drawing on decades of research spanning molecular cardio...

In this episode of Blindspot Capital , Maryann sits down with Lisa Suennen - longtime healthcare investor, founder of the Venture Valkyrie blog, and Managing Partner of the Go Red for Women Venture Fund to unpack one of the most misunderstood barriers in women’s health investing: the gap between mission and money . Lisa has been on every side of the table: as a founder, VC, nonprofit leader, and f...

In this episode of Blindspot Capital , Maryann sits down with Anna O’Sullivan, co-founder of censhership.co.uk and FutureFemHealth, to unpack a deeply underrecognized systemic bias: the routine censorship of women’s health content online. Over 95% of women's health brands report experiencing some form of suppression. Posts about menopause, fertility, libido, and endometriosis are being flagged as...

What if naming something was the first step to making it investable? In this episode of Blindspot Capital, I sit down with Ida Tin, entrepreneur, systems thinker, and the woman who coined the term FemTech . She’s also the co-founder and former CEO of Clue, one of the most widely used women’s health apps in the world, with over 10 million active users in 190+ countries. But this conversation isn’t...

Half the headlines in healthcare are hype. But what if we stopped chasing the next shiny thing and started fixing the fundamentals? In this episode of Blindspot Capital, I sit down with Sergei Polevikov , mathematician, investor, and co-host of the podcast Digital Health Inside Out , to talk about what’s broken in digital health from copycat AI startups to gender bias in funding and where we shoul...

Half the population experiences these conditions. Many are universal, recurring, and clinically significant. Yet in the eyes of too many investors, women’s health therapeutics remain “optional.” In this episode of Blindspot Capital , I sit down with Sabrina Johnson , President & CEO of Daré Bioscience , to unpack the misconceptions holding back investment in women’s health from contraception to me...

In this episode, healthcare investor and strategist Maryann Umoren Selfe is joined by Matthias Wipf, CEO of Swiss medtech company MOMM Diagnostics , to examine the systemic gaps in how we identify and fund life-saving healthcare infrastructure for women. 🟣 Why preeclampsia remains one of the most dangerous, misunderstood pregnancy complications 🟣 What point-of-care diagnostics like Pre-Exclude a...

Blind Spot Capital Podcast Trailer Welcome to Blind Spot Capital , the podcast where health innovation meets investment insight. Every year, investors bet billions on the future of health but most still miss one of the biggest opportunities in the market: women’s health. You tell a woman to “wait and see” while her organ shuts down? That’s not medicine. That’s neglect. We talk to the founders buil...

A few weeks ago, Ronald Vos and Nutte van Belzen, the founders of CC Diagnostics were at a major European medical congress when they were approached by a woman who didn’t work in science or medicine. She had bought an expensive delegate ticket, not to participate in the conference, but to seek help. She had advanced cervical cancer. And she came in the hope that someone…anyone, at this gathering o...

In this conversation, Maryann and Astrid Gyllenkrok, CEO and Co-Founder of LEIA Health discuss the challenges of parenthood, particularly focusing on the postpartum experience and the need for better support systems for new parents. Astrid shares her journey in founding LEIA, a Swedish startup on a mission to support the next one billion parents by digitising the parental journey, offering AI-powe...

In this episode of FemmeHealth Founders, Maryann speaks with Dr. Lara Zibners , co-founder of Calla Lily Clinical Care , about the inadequacies in current drug delivery methods for women's health. Lara shares her personal journey from being a physician to an entrepreneur, driven by her own experiences with infertility and the challenges of existing treatments. With a broad background in clinical m...

In this episode of Notes to Selfe , we dive into the fascinating world of women's health innovation with Sebastian Alexander , founder and CEO of VivoSensMedical. We explore the journey of OvulaRing , a groundbreaking technology transforming the way we understand and address female fertility and gynaecological diagnostics. From the legacy of Sebastian's father-in-law, a pioneer in IVF and reproduc...

Hormones rule our lives—from puberty to menopause, they influence everything from our mood to our health. But why do some women experience severe side effects while others don’t? In this episode of the FemmeHealth Founder Series , I sit down with Dr. Paulina Cecula , co-founder of Dama Health, to: 📌 explore the groundbreaking science behind personalized hormone therapy. 📌 discuss the complex int...